Case File: United States of America, ex rel. Gearhart & Griffieth (Creditor) vs. Remedi SeniorCare Holding Corporation (Debtor)
Case No.: 1:20cv970
Court: U.S. District Court, Southern District of Ohio
Settlement Amount: Over $5.3 million, set by Remedi’s ability to pay and paid over time
Announced: September 17, 2026
Period at Issue: January 1, 2015 through March 31, 2021
Whistleblowers: Maureen Gearhart and Laura Griffieth, both former Remedi employees
Status: Allegations only. There has been no determination of liability.
A prescription is the one piece of paper a pharmacy can’t do without. It is what tells the pharmacy a qualified prescriber actually ordered the drug, and it is what lets the pharmacy bill Medicare or Medicaid for it. According to the federal government, a Maryland pharmacy company filled and billed for drugs without that safeguard in place, and the drugs went to people living in assisted living facilities.
Remedi SeniorCare Holding Corporation, headquartered in Towson, Maryland, has agreed to pay more than $5.3 million to resolve those allegations, which the Justice Department announced on September 17, 2026. The company has not been found liable, and the settlement does not say otherwise. It does give a clear look at how a billing case about one missing requirement can add up over six years.
Who Is Remedi SeniorCare?
Remedi SeniorCare Holding Corporation is a long-term care pharmacy company based in Towson, Maryland. The Justice Department describes the business as dispensing prescription drugs to residents of assisted living facilities in various states, which is a very different customer base from the corner drugstore.
The people on the receiving end of these prescriptions are older adults who often depend on a pharmacy and a care facility to manage their medications for them. That detail matters to the government’s argument, because it is why officials describe the case as one about vulnerable people, not just paperwork.
What the Government Says Happened
The government’s allegation is short and specific. According to the Justice Department, from January 1, 2015 through March 31, 2021, Remedi submitted false claims to Medicare and Medicaid for prescription drugs that lacked valid prescriptions.
Broken down, the allegations are:
- The billing went to two federal programs, Medicare and Medicaid
- The drugs at issue were prescription medications that, according to the government, did not have valid prescriptions behind them
- The drugs were dispensed to residents of assisted living facilities in various states
- The conduct is alleged to have run for more than six years
One thing the Justice Department’s announcement does not do is explain exactly what made the prescriptions invalid. It states the allegation in general terms, and the details sit in the settlement agreement and the underlying lawsuit rather than in the press release.
Why a Valid Prescription Is the Whole Ballgame
In general terms, federal health programs pay for prescription drugs only when the medication was properly ordered. A valid prescription is the proof that a licensed prescriber made a medical decision about that patient, and it is also the pharmacy’s basis for billing the government.
When that step is missing, the problem goes past a clerical error. It means a claim sent to a taxpayer-funded program may not meet the program’s basic conditions, and under the False Claims Act, knowingly submitting such a claim can create liability. That is the legal theory behind this settlement.
The Whistleblowers Who Started It
This case did not begin with a government audit. It began with two former employees of the company.
Maureen Gearhart and Laura Griffieth filed a lawsuit under the whistleblower provisions of the False Claims Act, which let private individuals sue on the government’s behalf and share in any recovery. According to McKnight’s Senior Living, the case began in December 2020. It is captioned United States ex rel. Gearhart & Griffieth v. Remedi SeniorCare Holding Corp., et al., No. 1:20cv970, in the U.S. District Court for the Southern District of Ohio.
A few related details are worth knowing:
- The settlement provides for the whistleblowers to receive a share of the payments as they are made over time
- The Justice Department does not state the dollar amount or percentage of that share
- Gearhart also brought individual retaliation claims under the False Claims Act and Ohio law, which were resolved separately
In Their Own Words
The officials announcing the settlement kept coming back to the same two ideas: patient safety and the integrity of federal programs. Assistant Attorney General Brett A. Shumate of the Justice Department’s Civil Division said:
“When pharmacies dispense drugs without valid prescriptions, they undermine both patient safety and the integrity of vital federal healthcare programs.”
U.S. Attorney Dominick S. Gerace II of the Southern District of Ohio, whose office handled the case, said:
“Billing Medicare and Medicaid for prescription drugs without a valid prescription is unlawful and can present serious risks.”
Miranda L. Bennett, Acting Deputy Inspector General for Investigations at the Department of Health and Human Services’ Office of Inspector General, focused on the residents themselves:
“Billing Medicare and Medicaid for drugs dispensed without valid prescriptions puts residents of assisted living facilities at risk and undermines essential safeguards designed to protect patient health and federal health care programs.”
Paid Over Time, Based on Ability to Pay
The structure of the payment tells part of the story. According to the Justice Department, the settlement is based on Remedi’s ability to pay, and the money will be paid over time rather than in a single check. In Justice Department settlements, an ability-to-pay basis generally means the figure was set with the company’s finances in mind.
McKnight’s Senior Living reports that the first installment was approximately $1.19 million. The full payment schedule is in the settlement agreement the Justice Department linked from its announcement.
None of the coverage reviewed for this article includes a public statement from Remedi responding to the allegations.
Not the First Time Remedi Has Settled
This is not the first False Claims Act settlement in Remedi’s history. According to McKnight’s Senior Living, the company paid almost $1.3 million in 2010 to resolve a separate case.
In that earlier matter, Remedi was accused of submitting false claims to Medicare Part D, Medicaid, the Federal Employees Health Benefit Plan and TRICARE from January 2006 through December 2007. The allegation was that it billed for unused prescriptions that assisted living communities had returned, without giving the programs credit for them.
Both cases involve assisted living residents and pharmacy billing, but they involve different alleged conduct and different time periods, and each was resolved without a finding of liability.
Where This Fits in the Larger Push
The Justice Department placed the settlement inside a broader enforcement effort. Its announcement notes that this year the administration launched the Task Force to Eliminate Fraud and the National Fraud Enforcement Division, and says the Civil Division’s False Claims Act work will support that mission.
The pace of announcements shows the focus. Less than two weeks after the Remedi settlement, the Justice Department announced a $22.5 million settlement with Independence Blue Cross over Medicare Advantage diagnosis codes, along with a $20.5 million settlement with Signal Diagnostics over overpayments from a federal uninsured-patient program.
The Remedi matter was a coordinated effort between the Civil Division’s Commercial Litigation Branch, Fraud Section, and the U.S. Attorney’s Office for the Southern District of Ohio, with assistance from HHS-OIG and the Ohio Attorney General’s Office. It was handled by Fraud Section Senior Litigation Counsel Laurie A. Oberembt and Assistant U.S. Attorney Brandi Stewart.
The Takeaway
The Remedi settlement is small next to the biggest healthcare fraud cases of the year, but the allegation is easy to understand: a pharmacy is accused of billing federal programs for drugs that did not have valid prescriptions behind them, for people who were living in assisted care. The government says that is both a billing problem and a patient safety problem.
Remedi has not been found liable, and the settlement resolves the case without any court deciding who was right. What it does leave behind is a payment plan, a whistleblower case that started in 2020, and a reminder that a pharmacy’s paperwork is also the proof it relies on when it asks taxpayers to pay.
For anyone who wants to report suspected healthcare fraud, the Justice Department points to the Department of Health and Human Services tip line at 800-HHS-TIPS (800-447-8477).if the final collectible number still depends on what happens next at the appellate level.
SOURCE:
This article is based on the official Justice Department press release issued by the Office of Public Affairs on September 17, 2026, which was used to confirm the settlement amount, the allegation period, the case caption and number, the names of the whistleblowers, the payment structure, and the statements of Assistant Attorney General Brett A. Shumate, U.S. Attorney Dominick S. Gerace II and HHS-OIG’s Miranda L. Bennett. It is cross-referenced against coverage from McKnight’s Senior Living, which supplied the December 2020 filing date, the first installment amount, the separate retaliation claims, and the 2010 settlement, and against reporting from the Washington Times and a Maryland-focused enforcement roundup. The claims resolved by the settlement are allegations only, and there has been no determination of liability.